Skip to content

Perioperative Colloid vs Crystalloid in Patients Undergoing Colorectal Surgery

Balanced 6 % HES 130/0.4 vs. Balanced Crystalloid-based Infusion in Patients Undergoing Colorectal Surgery

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01303250
Acronym
KoKris
Enrollment
31
Registered
2011-02-24
Start date
2011-04-30
Completion date
2015-04-30
Last updated
2015-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery, Colorectal

Keywords

goal-directed fluid optimization, hemodynamic optimization, crystalloid, colloid

Brief summary

The primary purpose of this study is to determine the effect of a balanced 6%hydroxyethyl starch 130/0.4 vs. a balanced crystalloid in colorectal surgery. The intraoperative fluid management will be given to optimize the stroke volume variation \<= 12%. The investigators hypothesize that patients in the intervention group will need less fluid administration be optimal hemodynamic stabilized.

Interventions

DRUGbalanced 6% hydroxyethylstarch 130/0.4

Fluid administration and optimization based on cardiac output findings during surgery.

Fluid administration and optimization based on cardiac output findings during surgery.

Sponsors

Fresenius Kabi
CollaboratorINDUSTRY
University Hospital Muenster
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients undergoing elective colorectal surgery * minimum age 18 years * informed consent

Exclusion criteria

* patients with severe cardiomyopathy or severe heart failure * history of coagulation disorders * intracranial hemorrhage * patients with severe cardiovascular or respiratory disorders * renal insufficiency * severe liver diseases

Design outcomes

Primary

MeasureTime frameDescription
Total amount of administered fluidsintraoperativelyTotal amount of administered fluids intraoperatively that is necessary to keep patients optimal hemodynamic stabilized

Secondary

MeasureTime frame
Incidence of surgery related complicationsday 28 and 90 postoperatively

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026